Myasthenia Gravis Exacerbation Following COVID-19 Vaccine: A Case Report
Background: Vaccination remains the mainstay of strategy for prevention of Coronavirus Disease-2019 (COVID-19). AZD1222 (AstraZeneca vaccine) was distributed in Sudan by the COVID-19 Vaccines Global Access facility in March 2021. It was added to the emergency use list by the WHO in mid-February 202...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University Library System, University of Pittsburgh
2023-03-01
|
| Series: | International Journal of Medical Students |
| Subjects: | |
| Online Access: | https://ijms.info/IJMS/article/view/1455 |